Single-centre, single-blind, randomized, active-controlled phase-3 non-inferiority study to investigate the safety and efficacy of the cardioplegic solution Cardioplexol™
Authors
Sandra Folkmann
Hendrik T. Tevaearai Stahel (ORCID: https://orcid.org/0000-0001-9284-9842)
Gabriel Weiss (ORCID: https://orcid.org/0000-0003-4955-2714)
Bernard Voet
Piotr Landowski (ORCID: https://orcid.org/0000-0002-4070-4542)
Martin Grabenwöger (ORCID: https://orcid.org/0000-0001-7299-2801)
Single-centre, single-blind, randomized, active-controlled phase-3 non-inferiority study to investigate the safety and efficacy of the cardioplegic solution Cardioplexol™
Sandra Folkmann, Hendrik T. Tevaearai Stahel, Gabriel Weiss, Bernard Voet et al.
Citations
2 citations
Journal
Frontiers in Cardiovascular Medicine
Topics
Cardiac Ischemia and Reperfusion
Field-Weighted Citation Impact (FWCI)
2.94
article
Single-centre, single-blind, randomized, active-controlled phase-3 non-inferiority study to investigate the safety and efficacy of the cardioplegic solution Cardioplexol™
Sandra Folkmann, Hendrik T. Tevaearai Stahel, Gabriel Weiss, Bernard Voet, Piotr Landowski, Martin Grabenwöger, Marieluise Harrer
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
Frontiers in Cardiovascular MedicineVol. 12
Institutions
Sigmund Freud Privatuniversität Wien (AT), University Hospital of Bern (CH), Karl Landsteiner Society (AT)